Russian drugmaker R-Pharm is searching buyers for its flagship factory in Germany in the city of Illertissen, which was ...

The US eosinophilic esophagitis (EoE) market is projected to grow from $202 million in 2020 to $1.19 billion in 2030, ...

Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

Shares in Biohaven moved up about 7% on Friday after the company provided an update with respect to its New Drug Application (NDA) for troriluzole for the treatment of adult patients with ...

The European Commission has approved a new film-coated tablet formulation of Sino-American oncology-focused biotech BeOne Medicines’ Brukinsa (zanubrutinib) for all approved indications.

The US Food and Drug Administration (FDA) granted approval for a second treatment for metabolic dysfunction-associated ...

The range of drugs available in the Russian market may significantly decrease in the short term due to protectionist measures ...

By a vote of 5-4, the US Supreme Court on Thursday agreed to allow the National Institutes of Health, the largest public ...

The pharmaceutical industry and the UK government have failed to reach agreement on requested changes to a medicines payment ...

A week on from increases in the cost of Eli Lilly’s weight loss drug Mounjaro (tirzepatide), weight loss medication provider ...